MedAnnex is a dynamic biotechnology company developing new treatments for patients with autoimmune diseases.

Our novel monoclonal antibody – annexuzlimab – has shown significant activity in several autoimmune conditions, including rheumatoid arthritis and multiple sclerosis.

Latest News